BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, activates of human NADPH oxidase system from THP-1 cells a potential adjuvant for infection control of immunodeficient patients

E. B. Oliveira S. M Thomazzi; J Rehder; E Antunes; Antonio Condino Neto; LAGID Meeting of the Autoimmunity in Primary Immunodeficiencies (12. 2007 São Paulo); BRAGID Meeting of the Autoimmunity in Primary Immunodeficiencies (1. 2007 São Paulo)

Clinics São Paulo v. 62, suppl. 2, 2007

São Paulo 2007

Item não circula. Consulte sua biblioteca.(Acessar)